11/22/2024
4:33 PM | ARCH Venture Fund XII, L.P. (Filed by)
Neumora Therapeutics (Subject)
| Form SC 13D/A | |
11/12/2024
6:17 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
5:25 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:01 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:26 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:10 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:30 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/09/2024
3:10 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
4:22 PM | Neumora Therapeutics (Filer)
| Form S-3ASR | |
09/19/2024
3:35 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:37 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:22 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:18 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
4:58 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
5:17 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
8:48 AM | Neumora Therapeutics (Subject)
Pinto Joshua (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
6:15 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:15 PM | FMR LLC (Filed by)
Neumora Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/08/2024
12:07 PM | FMR LLC (Filed by)
Neumora Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/28/2024
8:00 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:18 PM | Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:15 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
4:00 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
5:46 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:34 PM | Neumora Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
6:08 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:21 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:13 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:14 PM | Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:15 PM | Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:32 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
